THEORETICAL-STUDY OF THE FLEXIBILITY AND SOLUTION CONFORMATION OF THE CYCLIC OPIOID-PEPTIDES [D-PEN2,D-PEN5]ENKEPHALIN AND [D-PEN2,L-PEN5]ENKEPHALIN

被引:0
|
作者
CHEW, C [1 ]
VILLAR, HO [1 ]
LOEW, GH [1 ]
机构
[1] MOLEC RES INST,845 PAGE MILL RD,PALO ALTO,CA 94304
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
An investigation of the conformational profiles of two cyclic delta-selective opioid peptides, [D-Pen2,D-Pen5]-enkephalin and [D-Pen2,L-Pen5]-enkephalin, has been made. The methods and procedures used are more extensive and systematic than those previously reported, involving a combination of nested grid rotations, cyclic ring-closing algorithms. molecular dynamic simulations at high and low temperature, and total geometry optimizations. The reexamination is a necessary first step in further characterization of the bioactive form of delta-selective peptides. This study also addresses the question of how rigid such cyclic analogs actually are. Finally, the effect of solvent environment on the low energy conformers obtained from the extensive search strategy has been determined. Simulation of the effect of water as a solvent by a continuum dielectric constant of 80 results in the breaking of internal hydrogen bonds and rearrangement of the rank order of energy of the conformers. The lowest energy solution conformation for [D-Pen2,D-Pen5]-enkephalin, obtained without utilizing any experimental data, is in excellent agreement with the geometric properties deduced from its solution NMR spectra.
引用
收藏
页码:502 / 510
页数:9
相关论文
共 50 条
  • [11] TRITIUM (D-PEN2, D-PEN5)ENKEPHALIN, A HIGHLY SELECTIVE RADIOLIGAND FOR THE IDENTIFICATION AND CHARACTERIZATION OF THE DELTA-OPIOID RECEPTOR
    YAMAMURA, HI
    AKIYAMA, K
    GEE, KW
    MOSBERG, HI
    HRUBY, VJ
    FEDERATION PROCEEDINGS, 1985, 44 (03) : 422 - 422
  • [12] Interactions of cocaine with morphine, U-50,488H and [D-Pen2,D-Pen5]enkephalin
    Bhargava, HN
    Cao, YJ
    PEPTIDES, 1998, 19 (03) : 563 - 568
  • [13] DELTA-OPIOID RECEPTOR-SELECTIVE LIGANDS - [D-PEN2,D-PEN5]ENKEPHALIN-DERMENKEPHALIN CHIMERIC PEPTIDES
    CAVAGNERO, S
    MISICKA, A
    KNAPP, RJ
    DAVIS, P
    FANG, L
    BURKS, TF
    YAMAMURA, HI
    HRUBY, VJ
    LIFE SCIENCES, 1991, 49 (07) : 495 - 503
  • [14] PARTIAL DEPLETION OF ENDOGENOUS ZINC LEVEL BY (D-PEN2,D-PEN5)ENKEPHALIN IN THE RAT-BRAIN
    GULYA, K
    KOVACS, GL
    KASA, P
    LIFE SCIENCES, 1991, 48 (12) : PL57 - PL62
  • [15] Differential down-regulation of the human δ-opioid receptor by SNC80 and [D-Pen2,D-Pen5]enkephalin
    Okura, T
    Cowell, SM
    Varga, E
    Burkey, TH
    Roeske, WR
    Hruby, VJ
    Yamamura, HI
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 387 (02) : R11 - R13
  • [16] NALOXONAZINE PRETREATMENT FAILS TO ALTER THE ANALGESIC EFFECT OF INTRACEREBROVENTRICULAR (D-PEN2, D-PEN5)ENKEPHALIN (DPDPE) IN THE MOUSE
    HEYMAN, JS
    MOSBERG, HI
    PORRECA, F
    FEDERATION PROCEEDINGS, 1986, 45 (04) : 1052 - 1052
  • [17] ROLE OF MU AND DELTA RECEPTORS IN THE SUPRASPINAL AND SPINAL ANALGESIC EFFECTS OF [D-PEN2, D-PEN5]ENKEPHALIN IN THE MOUSE
    PORRECA, F
    HEYMAN, JS
    MOSBERG, HI
    OMNAAS, JR
    VAUGHT, JL
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1987, 241 (02): : 393 - 400
  • [18] CONTRAVERSIVE CIRCLING INDUCED BY VENTRAL TEGMENTAL MICROINJECTIONS OF MODERATE DOSES OF MORPHINE AND [D-PEN2,D-PEN5]ENKEPHALIN
    JENCK, F
    BOZARTH, M
    WISE, RA
    BRAIN RESEARCH, 1988, 450 (1-2) : 382 - 386
  • [19] CENTRAL OPIOID MODULATION OF BREATHING DYNAMICS IN THE FETAL LAMB - EFFECTS OF [D-PEN2, D-PEN5]-ENKEPHALIN AND PARTIAL ANTAGONISM BY NALTRINDOLE
    CHENG, PY
    WU, DL
    DECENA, J
    CHENG, Y
    MCCABE, S
    SZETO, HH
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 262 (03): : 1004 - 1010
  • [20] Pharmacodynamic and pharmacokinetic characterization of poly(ethylene glycol) conjugation to met-enkephalin analog [D-Pen2,D-Pen5]-enkephalin (DPDPE)
    Witt, KA
    Huber, JD
    Egleton, RD
    Roberts, MJ
    Bentley, MD
    Guo, LH
    Wei, HB
    Yamamura, HI
    Davis, TP
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 298 (02): : 848 - 856